Home › Funds › Bollard Group LLC › TECX

Bollard Group LLC position in TECX

TECTONIC THERAPEUTIC · Health Care

Bollard Group LLC reported holding 302,953 shares of TECX (TECTONIC THERAPEUTIC) in its Q2 2026 13F filing — a position valued at US$10.4M, representing 0.34% of its reported portfolio and ranking #44 among its reported holdings. Bollard Group LLC has disclosed TECX holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)302.95K sh
Reported value held$10.41M
Portfolio Weight0.34%
First reportedQ1 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Bollard Group LLC's TECX position evolved

Bollard Group LLC first disclosed a stake in TECX in Q1 2025 at 302,953 shares (US$5.4M). The position peaked in Q2 2026 at 302,953 shares, worth US$10.4M. Across 6 filings, Bollard Group LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 302,953 shares valued at US$10.4M.

Quarter by quarter

QuarterSharesValueChange
Q1 2025 302.95K $5.37M New
Q2 2025 302.95K $6.02M Hold
Q3 2025 302.95K $4.75M Hold
Q4 2025 302.95K $6.32M Hold
Q1 2026 302.95K $9.36M Hold
Q2 2026 302.95K $10.41M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TECX and 13F data

TECX (TECTONIC THERAPEUTIC) is a Health Care company. 54 other funds we track also report a position in TECX — the largest reported positions include TCG Crossover Management, LLC (US$41.4M), First Light Asset Management, LLC (US$27.5M), 5AM Venture Management, LLC (US$20.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TECX

All TECX fund holders →

FAQ

How long has Bollard Group LLC held TECX?

Bollard Group LLC has disclosed TECX holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

What is Bollard Group LLC's current position in TECX?

As of Q2 2026, Bollard Group LLC holds 302.95K shares of TECX (TECTONIC THERAPEUTIC), valued at $10.41M, representing 0.34% of its reported portfolio and ranking #44.

Has Bollard Group LLC been buying or selling TECX?

In the latest 13F filing (Q2 2026), Bollard Group LLC held unchanged its position in TECX. The position peaked in Q2 2026 at 302.95K shares.

Which other funds hold TECX?

Other major institutional holders of TECX include TCG Crossover Management, LLC, First Light Asset Management, LLC, 5AM Venture Management, LLC, among 54 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.